Staphylococcus aureus exfoliative toxins: How they cause disease

Journal of Investigative Dermatology

Volumn 122, Issue 5, 2004, Pages 1070-1077

  Piano, Lisa R W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; DESMOGLEIN 1; DESMOGLEIN 3; EXFOLIATIN; EXFOLIATIVE TOXIN A; EXFOLIATIVE TOXIN B; SERINE PROTEINASE; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; UNCLASSIFIED DRUG;

BULLOUS SKIN DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; IMPETIGO BULLOSA; INFECTION RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC EPIDERMAL NECROLYSIS;

EID: 2442591437     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1747.2004.22144.x     Document Type: Review

References (79)

1. Adesiyun AA, Lenz W, Schaal KP: Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria. Microbiologica 14:357-362, 1991
2. Adkins B: T cell function in newborn mice and humans. Immunol. Today 20:330-335, 1999
3. Aktories K, Schmidt G, Just I: Rho GTPases as targets of bacterial protein toxins. Biol Chem 381:421-426, 2000
4. Amagai M: Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20:92-102, 1999
5. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR: Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nature Medicine 6:1275-1277, 2000
6. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR: Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol 118:845-850, 2002
7. Anderson LO: Differentiation and distribution of three types of exfoliative toxin produced by Staphylococcus aureus strain isolated from a horse phlegmon. FEMS Immunol Med Microbiol 20:301-310, 1998
8. Arbuthnott JP, Kent J, Lyell A, Gemmell CG: Studies of staphylococcal toxins in relation to toxic epidermal necrolysis (the scalded skin syndrome). Br. J. Derm. 86:35-39, 1972
9. Bailey CJ, Deazavedo J, Arbuthnott JP: A comparitive study of two serotypes of epidermolytic toxins from Staphylococcus aureus. Biochim. Biophys. Acta 624:111-120, 1980
10. Bailey CJ, Lockhart BP, Redpath MB, Smith TP: The epidermolytic (exfoliative) toxins of Staphylococcus aureus. Med. Microbiol. Immunol. 184:53-61, 1995
11. Bailey CJ, Redpath MB: The esterolytic activity of epidermolytic toxins. Biochem. J. 284:177-180, 1992
12. Bergdoll MS (1972) in The Staphylococci, ed. Cohen, J. O. (Wiley, New York), pp. 187-248.
13. Bergdoll MS (1983) in Staphylococci and Staphylococcal Infections, eds. Easmon, C. S. F. & Adlam, C. (Academic Press, London), Vol. 2, pp. 559-598.
14. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP: A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1:1017-1021, 1981
15. Bloster-Hautamaa DA, Kreiswirth BN, R.P. N, Schlievert PM: The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J. Bio. Chem. 261:15783-15786, 1986
16. Cavarelli J, Prevost G, Bourguet W, et al: The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure 5:813-824, 1997
17. Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morb. Mortal. Wkly. Rep. 46:765-766, 1997
18. Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. JAMA 283:597-598, 2000a
19. Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. Morb. Mortal. Wkly. Rep. 48:1165-1167, 2000b
20. Chitaev NA, Troyanovsky SM: Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol 138:193-201, 1997
21. Cribier B, Piemont Y, Grosshans E: Staphylococcal scalded skin syndrome in adults. J. Amer. Acad. Derm. 30:319-324, 1994
22. Dancer SJ, Garrett R, Saldanha J, Jhoti H, Evans R: The epidermolytic toxins are serine proteases. FEBS Lett. 268:129-132, 1990
23. Dancer SJ, Noble WC: Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin. J Clin Pathol 44:681-684, 1991
24. Elias PM, Fritsch P, Dahl MV, Wolff K: Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin. J Invest Dermatol 65:501-512, 1975
25. Firtsch P, Elias P, Varga J: The fate of Staphylococcal exfoliatin in newborn and adult mice. British J. Derm. 95:275-284, 1976
26. Gemmell CG: Staphylococcal scalded skin syndrome. J. Med. Microbiol. 43:318-327, 1995
27. Gillet Y, Issartel B, Vanhems P, et al: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759, 2002
28. Gravet A, Couppie P, Meunier O, et al: Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol 39:4349-4356, 2001
29. Hanakawa Y, Schechter NM, Lin C, et al: Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 110:53-60, 2002
30. Iandolo JJ: Genetic analysis of extracellular toxins of Staphylococcal aureus. Annu. Rev. Microbiol. 43:375-402, 1989
31. Ito Y, Funabashi Yoh M, Toda K, Shimazaki M, Nakamura T, Morita E: Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus. J Infect Chemother 8:256-261, 2002
32. Jarraud S, Lyon GJ, Figueiredo AM, et al: Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 182:6517-6522, 2000
33. Ji G, Beavis RC, Novick RP: Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci U S A 92:12055-12059, 1995
34. Kaper JB, Hacker J: Pathogenicity islands and other mobile virulence elements. (1999) Pathogenicity islands and other mobile virulence elements (ASM Press, Washington, DC).
35. Koch PJ, Franke W: Desmosomal cadherins: another growing multigene family of adhesion molecules. Current Biology 6:682-687, 1994
36. Kondo I, Sakurai S, Sarai Y, Futaki S: Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. J Clin Microbiol 1:397-400, 1975
37. Koning S, van Belkum A, Snijders S, et al: Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol 41:3017-3021, 2003
38. Kuroda M, Ohta T, Uchiyama I, et al: Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240, 2001
39. Ladhani S: Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect 7:301-307, 2001
40. Ladhani S, Evans RW: Staphylococcal scalded skin syndrome. Archives of Disease in Childhood 78:85-88, 1998
41. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM: Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded skin syndrome. Clin. Microbiol. Rev. 12:224-242, 1999
42. Lee CY, Schmidt JJ, Johnson-Winegar AD, Spero L, Iandolo JJ: Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus. J. Bacteriol. 169:3904-3909, 1987
43. Mackenzie A, Johnson W, B. H, Norrish B, Jamieson F: A prolonged outbreak of exfoliative toxin A-producing Staphylococcus aureus in a Newborn Nursery. Diagn. Microbiol. Infect. Dis. 21:69-75, 1995
44. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Arnagai M, Stanley JR: Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461-468, 1999
45. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 248:705-711, 1990
46. Melish ME: Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J. Pediatrics 78:958-967, 1971
47. Melish ME, Chen FS, Sprouse S, Stuckey M, Murata MS: Epidermolytic toxin in staphylococcal infection: toxin levels and host response. Zentralbl. Bakteriol. Suppl. 10:287-298, 1981
48. Melish ME, Glasgow LA: The staphylococcal scalded-skin syndrome. N. Engl. J. Med. 282:1114-1119, 1970
49. Monday SR, Vath GM, Ferens WA, et al: Unique superantigen activity of staphylococcal exfoliative toxins. J. Immunol. 162:4550-4559, 1999
50. Nilles LA, Parry DA, Powers EE, Angst BD, Wagner RM, Green KJ: Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome. Journal of Cell Science 99:809-821, 1991
51. Ninomiya J, Ito Y, Iwao T: Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis. Infection and Immunity 68:5044-5049, 2000
52. Novick RP: Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429-1449, 2003
53. Novick RP: Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 49:93-105, 2003
54. O'Toole P, Foster TJ: Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus. J. Bacteriol. 169:3910-3915, 1987
55. Oyake S, Oh-i T, Koga M: Staphylococcal scalded skin syndrome in a healthy adult. J Dermatol 28:145-148, 2001
56. Papageorgiou AC, Plano LRW, Collins CM, Acharya KR: Structural differences in Staphylococcus aureus exfoliative toxins A and B as revealed from their crystal structures. Submitted 1999
57. Piemont Y, Rasoamananjara D, Fouace JM, Bruce T: Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients. J. Clin. Microbiol. 19:417-420, 1984
58. Plano LRW, Adkins B, Woisnchnik M, Ewing R, Collins CM: Toxin levels in serum correlate with the development of Staphylococcal scalded skin syndrome in a murine model. Infection and Immunity 69:5193-5197, 2001
59. Plano LRW, Gutman DM, Woischnik M, Collins CM: Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens. Infection and Immunity. 68:3048-3052, 2000
60. Prevost G, Couppie P, Monteil H: Staphylococcal epidermolysins. Curr Opin Infect Dis 16:71-76, 2003
61. Prevost G, Rifai S, Chaix ML, Meyer S, Piemont Y: Is the His72, Asp120, Ser195 triad constituative of the catalytic site of staphylococcal exfoliative toxin A. (1992) Is the His72, Asp120, Ser195 triad constituative of the catalytic site of staphylococcal exfoliative toxin A. (Gustav Fischer, New York).
62. Prevost G, Rifai S, Chaix ML, Piemont Y: Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biologic activity. Infect. Immun. 59:3337-3339, 1991
63. Rago JV, Vath GM, Bohach GA, Ohlendorf DH, Schlievert PM: Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA). J Immunol 164:2207-2213, 2000
64. Rago JV, Vath GM, Tripp TJ, Bohach GA, Ohlendorf DH: Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte stimulating hormones. Infection and Immunity 68:2366-2368, 2000
65. Sato H, Matsumori Y, Tanabe T, Saito H, Shimizu A, Kawano J: A new type of staphylococcal exfoliative toxin from a Staphylococcus aureus strain isolated from a horse with phlegmon. Infect Immun 62:3780-3785, 1994
66. Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53:291-325, 1993
67. Sugai M, Hashimoto K, Kikuchi A, et al: Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem 267:2600-2604, 1992
68. Vath GM, Earhart CA, Monie DD, landola JJ, Schlievert PM, Ohlendorf DH: The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochem. 38:10239-10246, 1999
69. Vath GM, Earhart CA, Rago JV, et al: The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochem 36:1559-1566, 1997
70. Whittock NV: Genomic sequence analysis of the mouse desmoglein cluster reveals evidence for six distinct genes: characterization of mouse DSG4, DSG5, and DSG6. J Invest Dermatol 120:970-980, 2003
71. Whittock NV, Bower C: Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 120:523-530, 2003
72. Wiley BB, Rogolsky M: Molecular and serological differentiation of staphylococcal exfoliative toxin synthesized under chromosomal and plasmid control. Infect. Immun. 18:487-494, 1977
73. Wu H, Wang ZH, Yan A, et al: Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med 343:31-35, 2000
74. Yamaguchi T, Hayashi T, Takami H, et al: Phage conversion of exfoliative toxin A production in Staphylococcus aureus. Mol Microbiol 38:694-705, 2000
75. Yamaguchi T, Hayashi T, Takami H, et al: Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyl-transferase, EDIN-C. Infect Immun 69:7760-7771, 2001
76. Yamaguchi T, Nishifuji K, Sasaki M, et al: Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun 70:5835-5845, 2002
77. Yamaguchi T, Yokota Y, Terajima J, et al: Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 185:1511-1516, 2002
78. Hanakawa Y, Selwood T, Woo D, Lin C, Schechter NM, Stanley JR: Calcium-dependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J Invest Dermatol 121:383-389, 2003
79. Hanakawa Y, Schechter NM, Lin C, Nishifuji K, Amagai M, Stanley JR: Enzymatic and molecular characteristics of the efficiency and specificity of exfoliative toxin cleavage of desmoglein 1. J Biol Chem 279:5268-5277, 2004